Literature DB >> 1271152

Clotrimazole treatment of chronic mucocutaneous candidiasis.

S Leikin, R Parrott, J Randolph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1271152     DOI： 10.1016/s0022-3476(76)81133-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells.

Authors:  P A Rufo; L Jiang; S J Moe; C Brugnara; S L Alper; W I Lencer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 3.  Chronic mucocutaneous candidosis: a review.

Authors:  I K Aronson; K Soltani
Journal:  Mycopathologia       Date:  1976-12-10       Impact factor: 2.574

4.  The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera.

Authors:  P A Rufo; D Merlin; M Riegler; M H Ferguson-Maltzman; B L Dickinson; C Brugnara; S L Alper; W I Lencer
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.